Reliable and rapid characterization of functional FCN2 gene variants reveals diverse geographical patterns
- Olusola Ojurongbe†1, 2,
- Eman Abou Ouf†1,
- Hoang Van Tong1,
- Nguyen L Toan3,
- Le H Song4,
- Paola R Luz5,
- Iara JT Messias-Reason5,
- Dennis Nurjadi1,
- Philipp Zanger1,
- Jürgen FJ Kun1,
- Peter G Kremsner1 and
- Thirumalaisamy P Velavan1Email author
© Ojurongbe et al.; licensee BioMed Central Ltd. 2012
Received: 25 January 2012
Accepted: 23 April 2012
Published: 17 May 2012
Ficolin-2 coded by FCN2 gene is a soluble serum protein and an innate immune recognition element of the complement system. FCN2 gene polymorphisms reveal distinct geographical patterns and are documented to alter serum ficolin levels and modulate disease susceptibility.
We employed a real-time PCR based on Fluorescence Resonance Energy Transfer (FRET) method to genotype four functional SNPs including -986 G > A (#rs3124952), -602 G > A (#rs3124953), -4A > G (#rs17514136) and +6424 G > T (#rs7851696) in the ficolin-2 (FCN2) gene. We characterized the FCN2 variants in individuals representing Brazilian (n = 176), Nigerian (n = 180), Vietnamese (n = 172) and European Caucasian ethnicity (n = 165).
We observed that the genotype distribution of three functional SNP variants (−986 G > A, -602 G > A and -4A > G) differ significantly between the populations investigated (p < 0.0001). The SNP variants were highly linked to each other and revealed significant population patterns. Also the distribution of haplotypes revealed distinct geographical patterns (p < 0.0001).
The observed distribution of the FCN2 functional SNP variants may likely contribute to altered serum ficolin levels and this may depend on the different disease settings in world populations. To conclude, the use of FRET based real-time PCR especially for FCN2 gene will benefit a larger scientific community who extensively depend on rapid, reliable method for FCN2 genotyping.
KeywordsFRET Ficolin-2 Genotypes Haplotypes Distribution
Innate immune system has a pivotal role as a first line defense against any invading pathogens without previous exposure while signaling towards a specific adaptive immune response . Ficolin-2 encoded by the FCN2 gene located on chromosome 9q34 has eight exons and represent one such vital innate immune recognition protein that are involved in immune defense against pathogens . The exon 1 of the FCN2 encodes a smaller segment of the N-terminal amino acids whereas exons 2 and 3 encode the collagen-like domain. The fourth exon encodes the linker region and exons 5–8 encode the fibrinogen like binding domain (FBG). A part of exon 8 encodes the fibrinogen like binding domain and the rest encodes the 3' UTR region and the SNPs at exon 8 were believed to cause specific alterations of the FBG domain thus affecting the binding to the ligands . The ficolin-2 has a fibrinogen like domain that interacts with sugar moieties such as N-acetylglucosamine (GIcNAc) and other acetylated compounds present on the surface of the pathogens leading to complement activation [3, 4]. Also ficolin-2 is known to bind specifically to lipotechoic acid on the cell wall of gram positive bacteria and to 1, 3-β-D-glucan, components of fungal and yeast cell walls [5, 6]. Similar to Mannose binding lectin (MBL), ficolins are capable of binding to pathogen-associated molecular patterns (PAMPs) and in association with the enzymes MBL-associated serine proteases (MASP1 and MASP2), ficolin-2 initiates the complement lectin cascade . Studies have documented that three promoter polymorphisms of the FCN2 gene (−986 G > A, -602 G > A, and -4A > G) are significantly correlated in a gene dose dependent manner with either a twofold decrease or increase in the ficolin-2 concentrations in the serum . Also the FCN2 variant in exon 8 (+6424 G > T) with amino acid substitution (Ala258Ser) has been demonstrated earlier to have elevated binding capacity to GIcNAC than the major allele [4, 9].
The SNPs in the FCN2 gene had been studied in different world populations  and it was demonstrated that single nucleotide polymorphisms at positions–986 G > A, –602 G > A and –4A > G in the promoter region and SNP at position +6424 G > T in the coding region were significantly associated to several infectious diseases such as respiratory infections in children, rheumatic fever, rheumatic heart disease, leprosy, malaria [11–15], hepatitis B  and in cutaneous leishmaniasis . Because of its vital contribution in host immune defense, FCN2 genotyping provides genetic clues to elucidate the association with different infectious and autoimmune diseases. In recent decades the hybridization-based methodology using real-time PCR is widely used for SNP detection. Various probes such as hybridization probe (Hybprobe), SimpleProbe and molecular beacons [18, 19] are utilized for real-time PCR based genotyping approaches. In the present study, we genotyped and characterized four FCN2 functional SNP variants (−986 G > A, –602 G > A, –4A > G and +6424 G > T) in West Africans from Nigeria, South Americans from Brazil, South East Asians from Vietnam and Caucasians from Germany using an available rapid, reliable and cost effective FRET-RT-PCR methodology.
Genomic DNA isolation
DNA samples utilized for this study represented cohort from our previous study for Vietnamese population  and from our unpublished data for Nigerian, Brazilian and Caucasian individuals. The characterization of the FCN2 functional variants were investigated in individuals representing Brazilian (n = 176), Nigerian Youruba individuals (n = 180), Vietnamese (n = 172) representing Viet ethnicity and European Caucasian ethnicity (n = 165). Genomic DNA was isolated using QIAamp DNA -Blood Mini kit (Qiagen, Hilden, Germany). Informed written consent was obtained from the study volunteers. The study was approved by the ethics committee of the Hospital de Clínicas in Curitiba, Brazil, local ethics committee of the Ministry of Health, Abeokuta Ogun State, Nigeria, the institutional review board of the Tran Hung Dao Hospital, Hanoi, Vietnam, and the ethics committee of the Medical Faculty in Tübingen, Germany.
Primers and Probes and observed melting temperatures employed for FCN2 SNP detection
Oligonucleotide sequence (5′- 3′)
−986 G > A (rs3124952)
Forward (0.5 μM)
Reverse (0.05 μM)
Sensor (0.25 μM)
Anchor (0.25 μM)
−602 G > A (rs3124953)
Forward (0.05 μM)
Reverse (0.5 μM)
Sensor (0.15 μM)
Anchor (0.15 μM)
−4 A > G (rs17514136)
Forward (0.125 μM)
Reverse (0.5 μM)
Sensor (0.15 μM)
Anchor (0.15 μM)
+6424 G > T (rs7851696)
Forward (0.5 μM)
Reverse (0.05 μM)
Sensor (0.15 μM)
Anchor (0.15 μM)
In addition, the observed genotypes of FCN2 by real- time PCR were reconfirmed for their SNP variant by direct sequencing of the respective DNA fragments. Thirty randomly chosen DNA samples each from Brazilian, Nigerian, Vietnamese and Caucasians individuals were PCR amplified with appropriate primer pairs. The PCR products were purified using ExoSAP-IT® (Affymetrix, Inc Ohio, USA) and 1 μl of the purified product were directly used as templates for sequencing, using the BigDye terminator v. 2.0 cycle sequencing kit (Applied Biosystems, USA) on an ABI 3100 DNA sequencer, according to the manufacturer’s instructions. DNA polymorphisms were identified when assembled with the reference sequence of FCN2 gene (NG_011649.1) using the BioEdit http://www.mbio.ncsu.edu/BioEdit/bioedit.html] program.
Data had been analysed by StatView (http://www.statview.com) and the level of significance was set to P < 0.05. Normal Chi square and two tailed Fisher’s exact tests were executed to determine the differences in genotype and haplotype distributions in different ethnicities. Genotype or haplotype frequencies were determined by simple gene counting and by using the expectation-maximum (EM) algorithm. The significance of deviations from Hardy-Weinberg equilibrium was tested using the random-permutation procedure as implemented in the Arlequin v. 184.108.40.206 software. (http://lgb.unige.ch/arlequin). Linkage disequilibrium (LD) analysis was performed using Haploview v. 3.2 program.
Observed genotypes in four FCN2 gene variants in different world populations
Observed haplotypes of FCN2 gene variants in different world populations
G G A G
A G G G
A A A G
G G A T
A G A G
G G G G
A G G T
A A A T
A G A T
G G G T
G A A G
Ficolins are able to bind to specific ligand such as pathogen-associated molecular patterns (PAMPs) expressed on the surface of pathogens and trigger the complement cascade by interacting with mannose binding lectin associated serine proteases (MASPs) to swiftly contain the early infection. This study based on FRET- realtime PCR, characterized distinct genetic geographical patterns in the four functional FCN2 gene variants that are documented to alter the serum ficolin levels and disease susceptibility. In recent years, many studies have used larger cohort to investigate the contribution of FCN2 SNPs (−986 G > A, –602 G > A, –4A > G and +6424 G > T) to diseases outcome [11–15]. All these studies had employed the standard sequencing analysis and Taqman approach for investigation of these vital FCN2 SNPs. With increasing sample size, the mechanism of allelic discrimination and detection methodologies remain laborious and time consuming. In comparison to direct sequencing, our approach augments the attributes of rapid and reliable characterization of FCN2 variants. Moreover the employed methodology utilizes simple data analysis for accurate genotype calling with a limited turn over time of three hours for 72 samples for one single run. Of significance is that genotypes observed using the FRET-RT PCR method were reconfirmed for their polymorphism status by direct sequencing that justifies the reliability of this study procedure. In addition, the observed genotype distributions for the West African Nigerian (n = 180) and European Caucasian ethnicities (n = 165) across all four functional FCN2 variants (−986 G > A, –602 G > A, –4A > G and +6424 G > T) were consistent with published variant frequencies in West African Ghana population (n = 50) and European Denmark individuals (n = 60) . These consistent results yet auguments the methodology as well as the genetic charcterization utilized in the study procedure. A previous study had reported the use of Taqman probes for FCN2 gene polymorphisms detection with low conversion rate and difficulty in their assay optimization [8, 13]. The difference between the melting peaks of the major and minor alleles in our study were between 6°C to 10°C which makes it obviously possible to distinguish between the homozygotes and the heterozygote.
Earlier studies have documented that ficolin-2 serum concentration was distributed in a gene dose-dependent manner, i.e. homozygotes had either the highest or the lowest ficolin-2 concentrations, whereas heterozygotes had intermediate concentrations . Three polymorphism in the promoter region of the FCN2 gene (−986 G > A, –602 G > A, and –4A > G) were associated with variation in ficolin-2 serum levels, where as the FCN2 variant in exon 8 (+6424 G > T) with amino acid substitution non-polar to polar (Ala258Ser) has been demonstrated to have elevated binding capacity to GIcNAC than the major allele [4, 9]. From our results, we observed that only the genotypes of the promoter region (−986 G > A, –602 G > A, and –4A > G) of the FCN2 gene is distributed significantly in the different world populations and all these variants are reported to be associated with varying serum ficolin-2 levels. In line with the documented studies, our results reveal a homozygous excess in the investigated Nigerian and Vietnamese populations. The +6424 T allele that was identified to have an elevated binding capacity to GIcNAC was detected in low frequencies irrespective of the studied ethnicities. We also observed that –602 G > A genotypes were mostly homozygous (−602 GG) in Nigerian and Vietnamese populations and were not in hardy Weinberg equilibrium. This may aid the researchers to disregard this functional FCN2 variant (−602 G > A) for investigation in any case–control studies in Nigerian and Vietnamese populations. From our recent study in a Nigerian cohort, we observed that only the heterozygous variants –986 G > A, and –4A > G in the promoter region contributed to increased susceptibility to schistosomiasis (our unpublished data) whereas none of these variants were observed to contribute to hepatitis B disease outcome in a gene dose dependent manner .
The haplotypes distribution differed significantly across continents. The observed frequency of FCN2 haplotypes in European and Brazilian populations were far higher in comparison to haplotypes representing Vietnamese and Nigerian ethnicity. Moreover the haplotype patterns remained similar in Europeans and Brazilians. The recent genetic admixture by the inflow of European and other ethnic descendents to Brazil may be a plausible explanation for the observed trend. The frequency of haplotypes remained far less in Nigeria and Vietnam compared to other investigated populations and this may be due to a reduced ethnic admixture in these populations. Our earlier studies have inferred that the reconstructed haplotypes (−986/-602/-4/+6424) were shown to influence the predisposition to HBV outcome, leprosy and in rheumatoid heart disease [12, 14, 16] and in cutaneous leishmaniasis . In all these documented studies, only the haplotypes were observed to significantly contribute to the clinical manifestation of the diseases. All this direct towards a contribution of haplotypes to disease association may possibly be of far more significance rather than a genotype dependent association. Also it is likely that clinical significance of these haplotypes may vary also depending on disease context.
In summary, this study on the use of FRET based real-time PCR especially for FCN2 gene will benefit a larger scientific community who extensively depend on rapid, reliable method for FCN2 genotyping. To conclude, the observed ethnic differences in the FCN2 functional SNP variants is believed to affect the concentration and the function of the ficolins, that may probably contribute to the pathophysiological significance in different disease settings.
We would like to thank Andrea Weierich, Silvelia Grummes and Viola Galinat for the excellent technical helps in sequencing. Eman Abou Ouf received financial support from Ministry of Higher Education, Egypt during this work period. Dr. Olusola Ojurongbe was supported by Alexander von Humboldt foundation and Hoang van Tong was supported by Vietnamese Government scholarship.
- Medzhitov R: Recognition of microorganisms and activation of the immune response. Nature. 2007, 449: 819-826. 10.1038/nature06246.View ArticlePubMedGoogle Scholar
- Runza VL, Schwaeble W, Mannel DN: Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology. 2008, 213: 297-306. 10.1016/j.imbio.2007.10.009.View ArticlePubMedGoogle Scholar
- Endo Y, Matsushita M, Fujita T: The role of ficolins in the lectin pathway of innate immunity. Int J Biochem Cell Biol. 2011, 43: 705-712. 10.1016/j.biocel.2011.02.003.View ArticlePubMedGoogle Scholar
- Garred P, Honore C, Ma YJ, Rorvig S, Cowland J, Borregaard N, et al: The genetics of ficolins. J Innate Immun. 2009, 2: 3-16.View ArticlePubMedGoogle Scholar
- Garlatti V, Belloy N, Martin L, Lacroix M, Matsushita M, Endo Y, et al: Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO J. 2007, 26: 623-633. 10.1038/sj.emboj.7601500.View ArticlePubMedPubMed CentralGoogle Scholar
- Ma YG, Cho MY, Zhao M, Park JW, Matsushita M, Fujita T, et al: Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement. J Biol Chem. 2004, 279: 25307-25312. 10.1074/jbc.M400701200.View ArticlePubMedGoogle Scholar
- Krarup A, Thiel S, Hansen A, Fujita T, Jensenius JC: L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem. 2004, 279: 47513-47519. 10.1074/jbc.M407161200.View ArticlePubMedGoogle Scholar
- Munthe-Fog L, Hummelshoj T, Hansen BE, Koch C, Madsen HO, Skjodt K, et al: The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol. 2007, 65: 383-392. 10.1111/j.1365-3083.2007.01915.x.View ArticlePubMedGoogle Scholar
- Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, Garred P: Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet. 2005, 14: 1651-1658. 10.1093/hmg/ddi173.View ArticlePubMedGoogle Scholar
- Hummelshoj T, Munthe-Fog L, Madsen HO, Garred P: Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns. Mol Immunol. 2008, 45: 2508-2520. 10.1016/j.molimm.2008.01.003.View ArticlePubMedGoogle Scholar
- Chen X, Katoh Y, Nakamura K, Oyama N, Kaneko F, Endo Y, et al: Single nucleotide polymorphisms of Ficolin 2 gene in Behcet’s disease. J Dermatol Sci. 2006, 43: 201-205. 10.1016/j.jdermsci.2006.05.010.View ArticlePubMedGoogle Scholar
- de Messias-Reason I, Kremsner PG, Kun JF: Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J Infect Dis. 2009, 199: 801-804. 10.1086/597070.View ArticlePubMedGoogle Scholar
- Faik I, Oyedeji SI, Idris Z, de Messias-Reason IJ, Lell B, Kremsner PG, et al: Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria. Hum Immunol. 2011, 72: 74-79. 10.1016/j.humimm.2010.10.003.View ArticlePubMedGoogle Scholar
- Messias-Reason IJ, Schafranski MD, Kremsner PG, Kun JF: Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin Exp Immunol. 2009, 157: 395-399. 10.1111/j.1365-2249.2009.03975.x.View ArticlePubMedPubMed CentralGoogle Scholar
- Ruskamp JM, Hoekstra MO, Postma DS, Kerkhof M, Bottema RW, Koppelman GH, et al: Exploring the role of polymorphisms in ficolin genes in respiratory tract infections in children. Clin Exp Immunol. 2009, 155: 433-440. 10.1111/j.1365-2249.2008.03844.x.View ArticlePubMedPubMed CentralGoogle Scholar
- Hoang TV, Toan NL, Song LH, Ouf EA, Bock CT, Kremsner PG, et al: Ficolin-2 levels and FCN2 haplotypes influence hepatitis B infection outcome in Vietnamese patients. PLoS One. 2011, 6: e28113-10.1371/journal.pone.0028113.View ArticlePubMedGoogle Scholar
- Assaf A, Hoang TV, Faik I, Aebischer T, Kremsner PG, Kun JF, et al: Genetic evidence of functional ficolin-2 haplotype as susceptibility factor in cutaneous leishmaniasis. PLoS One. 2012, 7: e34113-10.1371/journal.pone.0034113.View ArticlePubMedPubMed CentralGoogle Scholar
- Kwok PY: Methods for genotyping single nucleotide polymorphisms. Annu Rev Genomics Hum Genet. 2001, 2: 235-258. 10.1146/annurev.genom.2.1.235.View ArticlePubMedGoogle Scholar
- Tsuchihashi Z, Dracopoli NC: Progress in high throughput SNP genotyping methods. Pharmacogenomics J. 2002, 2: 103-110. 10.1038/sj.tpj.6500094.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/13/37/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.